Multi-Institutional Registry for Prostate Cancer Radiosurgery
NCT ID: NCT01226004
Last Updated: 2019-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2010-07-31
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
NCT05241236
Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma
NCT02339948
MRI Guided SBRT for Localized Prostate Cancer
NCT03778112
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
NCT06325046
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT03541850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The registry is designed to track surrogate treatment endpoints including PSA, IPSS, SHIM, QOL, Karnofsky Performance Status, VAS scores, urine and bowel health, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries.
FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* early or intermediate risk
Exclusion Criteria
18 Years
90 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RPCR, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark L. Perman, MD
Role: PRINCIPAL_INVESTIGATOR
South Florida Radiation Oncology, LLC.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CyberKnife of Birmingham
Birmingham, Alabama, United States
University of South Alabama-USA Mitchell Cancer Institute
Mobile, Alabama, United States
Phoenix CyberKnife & Radiation Oncology Center
Phoenix, Arizona, United States
California Cancer Care
Fresno, California, United States
Newport Diagnostic Center
Newport Beach, California, United States
Scripps Clinic Radiation Therapy Centers
San Diego, California, United States
Skyline Radiation Oncology
Tustin, California, United States
Penrose Cancer Center
Colorado Springs, Colorado, United States
Colorado CyberKnife
Lafayette, Colorado, United States
Anova Cancer Care
Lone Tree, Colorado, United States
Georgetown University
Washington D.C., District of Columbia, United States
CyberKnife Center of Miami
Miami, Florida, United States
Naples Radiation Oncology
Naples, Florida, United States
Memorial Cancer Institute CyberKnife Center
Pembroke Pines, Florida, United States
CyberKnife Center of South Florida in Stuart
Stuart, Florida, United States
CyberKnife Centers of Tampa Bay
Tampa, Florida, United States
WellStar Research Insititute
Marietta, Georgia, United States
CyberKnife Center of Chicago
Elmhurst, Illinois, United States
Illinois Cyberknife
Park Ridge, Illinois, United States
Baptist Health
Lexington, Kentucky, United States
Saint Vincent Frontier Cancer Center
Billings, Montana, United States
Benefis Sletten Cancer Institute
Great Falls, Montana, United States
Montana Cancer Institute Foundation
Missoula, Montana, United States
St. Elizabeth CyberKnife Center
Lincoln, Nebraska, United States
Las Vegas CyberKnife
Henderson, Nevada, United States
Reno CyberKnife
Reno, Nevada, United States
Riverview Medical Center
Red Bank, New Jersey, United States
United Health Services
Johnson City, New York, United States
First Dayton Cancer Care
Kettering, Ohio, United States
St. John Medical Center
Tulsa, Oklahoma, United States
Oklahoma CyberKnife
Tulsa, Oklahoma, United States
Cancer Treatment Centers of America
Tulsa, Oklahoma, United States
Philadelphia CyberKnife
Havertown, Pennsylvania, United States
Sarah Cannon Cancer Center
Nashville, Tennessee, United States
Austin CyberKnife
Austin, Texas, United States
Premier Cancer Centers
Dallas, Texas, United States
The Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
St. Luke's Medical Center
Houston, Texas, United States
The START Center for Cancer Care
San Antonio, Texas, United States
Cyberknife of Texas at East Texas Medical Center
Tyler, Texas, United States
Inova Fairfax Hospital
Falls Church, Virginia, United States
Spokane CyberKnife
Spokane Valley, Washington, United States
PeaceHealth Southwest Medical Center
Vancouver, Washington, United States
St. Mary's Medical Center
Huntington, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gregg Dickerson, MD
Role: primary
Gail Suarez
Role: primary
Mark Perman, MD
Role: primary
Beth Kost
Role: primary
Kathy Corbett
Role: primary
Katherine Wood
Role: primary
Role: backup
Gail Wade
Role: primary
Mathew
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FRRA01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.